Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have had a standard MRI scan of the prostate that included specific types of imaging (called T2WI, cDWI, hrDWI, and ADC maps) (confirm with trial site if unsure which scans you had)
- Your medical records and health information are complete and available
Who may not be able to join:
- You are currently taking or have taken medications called 5-alpha-reductase inhibitors (a type of drug sometimes used for enlarged prostate or hair loss) within the last six months
- You have previously had a prostate biopsy (a procedure where a small sample of prostate tissue was removed for testing)
- You have previously had prostate surgery of any kind
- You have previously received any treatment for prostate cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fei-Yun Wu, The First Affiliated Hospital with Nanjing Medical University
Phone: 86-18251966069
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
image quality evaluation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.